{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:00:04Z","timestamp":1793228404338,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Visual hallucinations (VH) are common in patients with Parkinson\u2019s disease (PD), yet the underlying pathophysiological mechanisms are still unclear. We aimed to explore the association of the presence of VH with inner retinal thinning and, secondarily, with visual acuity. To this end, we included 40 PD patients in this exploratory study, of whom 14 had VH, and 22 age- and sex-matched healthy controls. All participants were interviewed for the presence of VH by a neurologist specialized in movement disorders and underwent a thorough ophthalmologic examination, including measurement of the best-corrected visual acuity (BCVA) and optical coherence tomography to obtain macular scans of the combined ganglion cell layer and inner plexiform layer (GCL-IPL). Patients with VH had a thinner GCL-IPL than patients without VH, which persisted after correction for age, disease stage, levodopa equivalent daily dose (LED) and cognitive function. Furthermore, BCVA was lower in the PD\u00a0group with VH than in the PD\u00a0group without VH, although only a trend remained after correction for age, disease stage, LED and cognitive function. Taken together, in patients with PD, visual hallucinations appear to be associated with a thinning of the inner retinal layers and, possibly, with reduced visual acuity. Further research using a longitudinal design is necessary to confirm these findings and to establish the causality of these relationships.<\/jats:p>","DOI":"10.1038\/s41598-020-77833-1","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T11:02:35Z","timestamp":1606993355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Visual hallucinations in Parkinson\u2019s disease are associated with thinning of the inner retina"],"prefix":"10.1038","volume":"10","author":[{"given":"F.","family":"Visser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. I.","family":"Apostolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M. M.","family":"Vlaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W. R.","family":"Twisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. C.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. W.","family":"Berendse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"77833_CR1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/jnnp.70.6.734","volume":"70","author":"S Holroyd","year":"2001","unstructured":"Holroyd, S., Currie, L. & Wooten, G. F. Prospective study of hallucinations and delusions in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 70, 734\u2013738 (2001).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"77833_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/gps.3869","volume":"28","author":"G Gibson","year":"2013","unstructured":"Gibson, G. et al. Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson\u2019s disease: a longitudinal 4-year study. Int. J. Geriatr. Psychiatry 28, 626\u2013631 (2013).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"77833_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1179\/1743132814Y.0000000418","volume":"37","author":"RL Gama","year":"2015","unstructured":"Gama, R. L. et al. Risk factors for visual hallucinations in patients with Parkinson\u2019s disease. Neurol. Res. 37, 112\u2013116 (2015).","journal-title":"Neurol. Res."},{"key":"77833_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","volume":"13","author":"DH Ffytche","year":"2017","unstructured":"Ffytche, D. H. et al. The psychosis spectrum in Parkinson disease. Nat. Rev. Neurol. 13, 81\u201395 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"77833_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1017\/S0140525X05000130","volume":"28","author":"D Collerton","year":"2005","unstructured":"Collerton, D., Perry, E. & McKeith, I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav. Brain Sci. 28, 737\u2013757 (2005) (Discussion 757\u2013794).","journal-title":"Behav. Brain Sci."},{"key":"77833_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pneurobio.2014.01.004","volume":"116","author":"JM Shine","year":"2014","unstructured":"Shine, J. M., O\u2019Callaghan, C., Halliday, G. M. & Lewis, S. J. Tricks of the mind: Visual hallucinations as disorders of attention. Prog. Neurobiol. 116, 58\u201365 (2014).","journal-title":"Prog. Neurobiol."},{"key":"77833_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/mds.20263","volume":"20","author":"AD de Maindreville","year":"2005","unstructured":"de Maindreville, A. D., Fenelon, G. & Mahieux, F. Hallucinations in Parkinson\u2019s disease: a follow-up study. Mov. Disord. 20, 212\u2013217 (2005).","journal-title":"Mov. Disord."},{"key":"77833_CR8","first-page":"2473","volume":"31","author":"C Harnois","year":"1990","unstructured":"Harnois, C. & Di Paolo, T. Decreased dopamine in the retinas of patients with Parkinson\u2019s disease. Invest. Ophthalmol. Vis. Sci. 31, 2473\u20132475 (1990).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"77833_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neulet.2014.04.027","volume":"571","author":"TG Beach","year":"2014","unstructured":"Beach, T. G. et al. Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson\u2019s disease subjects. Neurosci. Lett. 571, 34\u201338 (2014).","journal-title":"Neurosci. Lett."},{"key":"77833_CR10","doi-asserted-by":"publisher","first-page":"7274","DOI":"10.1002\/mds.27392","volume":"33","author":"I Ortuno-Lizaran","year":"2018","unstructured":"Ortuno-Lizaran, I. et al. Phosphorylated alpha-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity. Mov. Disord. 33, 7274\u20137284 (2018).","journal-title":"Mov. Disord."},{"key":"77833_CR11","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ana.24182","volume":"75","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner, I., Kozlowski, P. B., Glazman, S. & Miri, S. alpha-synuclein in the inner retina in parkinson disease. Ann. Neurol. 75, 964\u2013966 (2014).","journal-title":"Ann. Neurol."},{"key":"77833_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.04.023","volume":"64","author":"A Chrysou","year":"2019","unstructured":"Chrysou, A., Jansonius, N. M. & van Laar, T. Retinal layers in Parkinson\u2019s disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat. Disord. 64, 40\u201349 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"77833_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ajo.2013.09.028","volume":"157","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin, E. et al. Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am. J. Ophthalmol. 157, 470-478.e472 (2014).","journal-title":"Am. J. Ophthalmol."},{"key":"77833_CR14","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00702-018-1872-6","volume":"125","author":"F Visser","year":"2018","unstructured":"Visser, F. et al. In vivo exploration of retinal nerve fiber layer morphology in Parkinson\u2019s disease patients. J. Neural Trans. 125, 931\u2013936 (2018).","journal-title":"J. Neural Trans."},{"key":"77833_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mds.25543","volume":"29","author":"JY Lee","year":"2014","unstructured":"Lee, J. Y. et al. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson\u2019s disease. Mov. Disord. 29, 61\u201367 (2014).","journal-title":"Mov. Disord."},{"key":"77833_CR16","first-page":"709191","volume":"2015","author":"A Kopal","year":"2015","unstructured":"Kopal, A. et al. Changes of retina are not involved in the genesis of visual hallucinations in Parkinson\u2019s disease. Parkinson\u2019s Dis. 2015, 709191 (2015).","journal-title":"Parkinson's Dis."},{"key":"77833_CR17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27728","volume":"34","author":"A Murueta-Goyena","year":"2019","unstructured":"Murueta-Goyena, A. et al. Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases. Mov. Disord. 34, 1315\u20131324 (2019).","journal-title":"Mov. Disord."},{"key":"77833_CR18","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/mds.23891","volume":"26","author":"NK Archibald","year":"2011","unstructured":"Archibald, N. K., Clarke, M. P., Mosimann, U. P. & Burn, D. J. Visual symptoms in Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Mov. Disord. 26, 2387\u20132395 (2011).","journal-title":"Mov. Disord."},{"key":"77833_CR19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1167\/iovs.16-20460","volume":"58","author":"M Satue","year":"2017","unstructured":"Satue, M. et al. Evaluation of progressive visual dysfunction and retinal degeneration in patients with Parkinson\u2019s disease. Invest. Ophthalmol. Vis. Sci. 58, 1151\u20131157 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"77833_CR20","doi-asserted-by":"publisher","first-page":"e009658","DOI":"10.1136\/bmjopen-2015-009658","volume":"6","author":"V Polo","year":"2016","unstructured":"Polo, V. et al. Visual dysfunction and its correlation with retinal changes in patients with Parkinson\u2019s disease: an observational cross-sectional study. BMJ Open 6, e009658 (2016).","journal-title":"BMJ Open"},{"key":"77833_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00702-013-1072-3","volume":"121","author":"M Schneider","year":"2014","unstructured":"Schneider, M. et al. Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. J. Neural Trans. 121, 41\u201347 (2014).","journal-title":"J. Neural Trans."},{"key":"77833_CR22","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/mds.25896","volume":"29","author":"NM Roth","year":"2014","unstructured":"Roth, N. M. et al. Photoreceptor layer thinning in idiopathic Parkinson\u2019s disease. Mov. Disord. 29, 1163\u20131170 (2014).","journal-title":"Mov. Disord."},{"key":"77833_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/WNO.0000000000000203","volume":"35","author":"ES Sari","year":"2015","unstructured":"Sari, E. S., Koc, R., Yazici, A., Sahin, G. & Ermis, S. S. Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration. Journal of Neuro-ophthalmol. 35, 117\u2013121 (2015).","journal-title":"Journal of Neuro-ophthalmol."},{"key":"77833_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10072-018-3244-2","volume":"39","author":"M Unlu","year":"2018","unstructured":"Unlu, M., Gulmez Sevim, D., Gultekin, M. & Karaca, C. Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson\u2019s disease. Neurol. Sci. 39, 533\u2013541 (2018).","journal-title":"Neurol. Sci."},{"key":"77833_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrneurol.2009.62","volume":"5","author":"NJ Diederich","year":"2009","unstructured":"Diederich, N. J., Fenelon, G., Stebbins, G. & Goetz, C. G. Hallucinations in Parkinson disease. Nat. Rev. Neurol. 5, 331\u2013342 (2009).","journal-title":"Nat. Rev. Neurol."},{"key":"77833_CR26","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/112067210701700520","volume":"17","author":"GF Yavas","year":"2007","unstructured":"Yavas, G. F., Yilmaz, O., Kusbeci, T. & Ozturk, F. The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. Eur. J. Ophthalmol. 17, 812\u2013816 (2007).","journal-title":"Eur. J. Ophthalmol."},{"key":"77833_CR27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5301\/ejo.5000338","volume":"24","author":"A Sen","year":"2014","unstructured":"Sen, A., Tugcu, B., Coskun, C., Ekinci, C. & Nacaroglu, S. A. Effects of levodopa on retina in Parkinson disease. Eur. J. Ophthalmol. 24, 114\u2013119 (2014).","journal-title":"Eur. J. Ophthalmol."},{"key":"77833_CR28","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00415-019-09430-w","volume":"266","author":"F Visser","year":"2019","unstructured":"Visser, F. et al. Diplopia in Parkinson\u2019s disease: visual illusion or oculomotor impairment?. J. Neurol. 266, 2457\u20132464 (2019).","journal-title":"J. Neurol."},{"key":"77833_CR29","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/jnnp.64.5.588","volume":"64","author":"DR Royall","year":"1998","unstructured":"Royall, D. R., Cordes, J. A. & Polk, M. CLOX: an executive clock drawing task. J. Neurol. Neurosurg. Psychiatry 64, 588\u2013594 (1998).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"77833_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1468-1331.2012.03701.x","volume":"20","author":"C La Morgia","year":"2013","unstructured":"La Morgia, C. et al. Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern?. Eur. J. Neurol. 20, 198\u2013201 (2013).","journal-title":"Eur. J. Neurol."},{"key":"77833_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman, K. J. No adjustments are needed for multiple comparisons. Epidemiol 1, 43\u201346 (1990).","journal-title":"Epidemiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77833-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:26:41Z","timestamp":1670372801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77833-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["77833"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-77833-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"assertion":[{"value":"15 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21110"}}